Trials / Completed
CompletedNCT03487588
An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses
An Open-Label Study Assessing Subject Satisfaction With A-101 Hydrogen Peroxide Topical Solution, 40% (w/w) Treatment for Seborrheic Keratoses of the Face, Neck, and Decolletage
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Aclaris Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 30 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is an open-label study designed to evaluate subject's satisfaction after treatment of seborrheic keratoses with A-101 40%.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | A-101 Topical Solution | A-101 Topical Solution applied Day 1, Day 15 and Day 29 |
Timeline
- Start date
- 2018-03-21
- Primary completion
- 2018-11-14
- Completion
- 2018-11-14
- First posted
- 2018-04-04
- Last updated
- 2019-10-02
- Results posted
- 2019-10-02
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03487588. Inclusion in this directory is not an endorsement.